<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BPOVF9RC</identifier><date>2004</date><creator>Mlakar, Uroš</creator><relation>documents/doc/B/URN_NBN_SI_doc-BPOVF9RC_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BPOVF9RC_001.txt</relation><format format_type="type">article</format><format format_type="extent">str. I-55-I-58</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">17680601</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BPOVF9RC</identifier><language>slv</language><publisher publisher_location="[Ljubljana]">Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Anemia, Hemolytic, Autoimmune</subject><subject language_type_id="slv">Anemija hemolitična, avtoimunska</subject><subject language_type_id="slv">Antibodies, Monoclonal</subject><subject language_type_id="slv">Antigeni, CD20</subject><subject language_type_id="slv">Antigens, Cd20</subject><subject language_type_id="slv">Autoantibodies</subject><subject language_type_id="slv">Avtoprotitelesa</subject><subject language_type_id="slv">Drug Therapy</subject><subject language_type_id="slv">Limfom malih limfocitov</subject><subject language_type_id="slv">Lymphoma, Small Lymphocytic</subject><subject language_type_id="slv">Middle Age</subject><subject language_type_id="slv">Protitelesa monoklonska</subject><subject language_type_id="slv">Srednja leta</subject><subject language_type_id="slv">Therapeutic Use</subject><subject language_type_id="slv">Treatment Outcome</subject><subject language_type_id="slv">Zdravljenje, izid</subject><title>Treatment of autoimmune hemolytic anaemia with rituximab</title><title>Zdravljenje avtoimunske hemolitične anemije z rituksimabom</title></Record>